What is it, and why does it matter? Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as ...

Please provide your email address to receive an email when new articles are posted on . Samples of Vizz are now going out to U.S. eye care providers, with commercial availability expected in the ...

Vizz (aceclidine), is an eye drop designed to help people who have presbyopia, which is a decline in your eye's ability to focus clearly on things close to you. Things at a distance may or may not be ...

For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...

The U.S. Food and Drug Administration (FDA) has given its stamp of approval to VIZZ, a revolutionary eye drop that offers a solution for people over 40 struggling with presbyopia. This condition, ...

A new prescription eye drop that could potentially allow many people to put down their reading glasses has been approved by the U.S. Food and Drug Administration (FDA). Known as Vizz, manufactured by ...

MHRA submission follows EMA validation of the VIZZ MAA in March 2026 Sixth ex-U.S. regulatory submission for VIZZ underscores accelerating global expansion SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) - ...

Prescription growth: VIZZ filled prescriptions increased from the prior quarter, with $1.7 million in net product revenue and signs of stronger repeat prescribing patterns. Targeted outreach: LENZ is ...

MAA submission to the European Medicines Agency represents a key regulatory milestone in LENZ’s strategy to expand global access to VIZZ Submission of MAA in Europe results in the fifth ex-U.S.